The blood viscometer market has seen considerable growth due to a variety of factors.
• In recent times, the blood viscometer market has seen substantial growth. The projected increase is from $1.69 billion in 2024 to $1.79 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%.
This increase during the historic period is due to enhancements in diagnostic technology, a heightened emphasis on managing diabetes, a rise in awareness of blood conditions, an aging population, and the expansion of personalized medicine.
The blood viscometer market is expected to maintain its strong growth trajectory in upcoming years.
• Over the coming years, the blood viscometer market is predicted to experience robust expansion. By 2029, it's estimated to reach a value of $2.22 billion with a compound annual growth rate (CAGR) of 5.6%.
The projected growth within this period is due to factors such as the advent of portable viscometers, emphasis on preventative healthcare, proliferation of point-of-care testing, amplified investment in healthcare facilities, and enhancements in clinical research and drug evolution. Emerging trends in this period encompass the incorporation of intelligent and digital technologies, growing preference for non-invasive testing methods, augmented usage in chronic disease treatment, the invention of automated viscometers, and escalated research in blood conditions and treatments.
The increasing occurrence of cardiovascular disorders is anticipated to fuel the expansion of the blood viscometer market in the near future. Cardiovascular disease, which encompasses various disorders affecting the heart and blood vessels, often results in heart attacks, strokes, or other heart-related ailments. Factors such as poor dietary habits, lack of physical activity, smoking, and the rise in obesity and diabetes rates, coupled with aging populations, largely contribute to the escalating occurrence of cardiovascular disease. A blood viscometer plays a vital role in cardiovascular disease management by measuring blood viscosity, which enables the evaluation of the thickness or thinness of the blood, a factor that can influence circulation and amplify the risk of heart attacks, strokes, or blood clots. For example, a report released by the American College of Cardiology in August 2022 states that in the United States, all four primary cardiovascular risk factors are projected to surge from 2025 to 2060. The largest anticipated increase is in the number of diabetes cases, going up by 39.3% to 55 million, followed by dyslipidemia with an increase of 27.6% to 126 million, then hypertension with a rise of 25.1% to 162 million, and obesity increasing by 18.3% to 126 million. Hence, the escalating occurrence of cardiovascular disease underlines the growth of the blood viscometer market.
The blood viscometermarket covered in this report is segmented –
1) By Product: Rotational Viscometers, Capillary Viscometers, Other Products
2) By Application: Blood Viscosity Measurement, Plasma Viscosity Measurement, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users
Subsegments:
1) By Rotational Viscometers: Brookfield Viscometers, Cone-And-Plate Viscometers, Digital Rotational Viscometers
2) By Capillary Viscometers: Ostwald Viscometers, Ubbelohde Viscometers, Microcapillary Viscometers
3) By Other Products: Vibro Viscometers, Optical Viscometers, Falling Ball Viscometers
Leading corporations in the blood viscometer market are concentrating on producing innovative products like automated viscometers for a competitive advantage. Automated viscometers are instruments that automatically calculate the viscosity of liquids without human involvement. For example, Sofraser, a company based in France, introduced the INVI viscometer in March 2023. The INVI viscometer is defined by its compact, inline design that permits constant, real-time viscosity evaluation without manual sampling. This robust device delivers precise results even under severe industrial circumstances, and it operates without maintenance and exhibits minimal deterioration. Notably, the INVI viscometer can be seamlessly incorporated into prevailing systems for enhanced process management.
Major companies operating in the blood viscometer market are:
• Thermo Fisher Scientific Inc.
• Emerson Electric Co
• Xylem Analytics
• PerkinElmer Inc.
• Qualitest
• Anton Paar GmbH
• AMETEK Brookfield
• BYK Gardner
• PAC LP.
• CANNON Instrument Company
• Koehler Instrument Company Inc.
• PCE Instruments
• RheosenseInc.
• Orbit Research Associates Pvt. Ltd.
• Swastik Systems & Services
• Lamy Rheology
• Fann Instrument Company
• Labomat Essor.
• Edutek Instrumentation
• Lasany International
North America was the largest region in the blood viscometer market in 2024. The regions covered in the blood viscometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.